Form 8-K - Current report:
SEC Accession No. 0001104659-25-064145
Filing Date
2025-06-30
Accepted
2025-06-30 16:30:29
Documents
12
Period of Report
2025-06-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2518735d3_8k.htm   iXBRL 8-K 25618
  Complete submission text file 0001104659-25-064145.txt   193450

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ganx-20250630.xsd EX-101.SCH 3038
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ganx-20250630_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ganx-20250630_pre.xml EX-101.PRE 22374
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2518735d3_8k_htm.xml XML 3800
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 251092504
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)